Ōsaka-sayama

The trials here

What the trial at this site is about, from its registry record.

Conditions

• Liver and biliary tract cancer

Closed trials

• Completed

  A Study of Relatlimab in Combination With Nivolumab in Participants With Advanced Liver Cancer Who Have Never Been Treated With Immuno-oncology Therapy After Prior Treatment With Tyrosine Kinase Inhibitors

  NCT04567615· Phase 2· Bristol-Myers Squibb· Source